Diabetic cardiomyopathy and metabolic remodeling of the heart

Pavan K. Battiprolu, Camila Lopez-Crisosto, Zhao Wang, Andriy Nemchenko, Sergio Lavandero, Joseph A Hill

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

The incidence and prevalence of diabetes mellitus are both increasing rapidly in societies around the globe. The majority of patients with diabetes succumb ultimately to heart disease, much of which stems from atherosclerotic disease and hypertension. However, the diabetic milieu is itself intrinsically noxious to the heart, and cardiomyopathy can develop independent of elevated blood pressure or coronary artery disease. This process, termed diabetic cardiomyopathy, is characterized by significant changes in the physiology, structure, and mechanical function of the heart. Presently, therapy for patients with diabetes focuses largely on glucose control, and attention to the heart commences with the onset of symptoms. When the latter develops, standard therapy for heart failure is applied. However, recent studies highlight that specific elements of the pathogenesis of diabetic heart disease are unique, raising the prospect of diabetes-specific therapeutic intervention. Here, we review recently unveiled insights into the pathogenesis of diabetic cardiomyopathy and associated metabolic remodeling with an eye toward identifying novel targets with therapeutic potential.

Original languageEnglish (US)
Pages (from-to)609-615
Number of pages7
JournalLife Sciences
Volume92
Issue number11
DOIs
StatePublished - 2013

Fingerprint

Diabetic Cardiomyopathies
Medical problems
Heart Diseases
Therapeutics
Cardiomyopathies
Coronary Artery Disease
Diabetes Mellitus
Heart Failure
Blood pressure
Physiology
Blood Pressure
Hypertension
Glucose
Incidence

Keywords

  • Diabetic cardiomyopathy
  • FoxO
  • Heart
  • Insulin resistance
  • Metabolism
  • mTOR

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Battiprolu, P. K., Lopez-Crisosto, C., Wang, Z., Nemchenko, A., Lavandero, S., & Hill, J. A. (2013). Diabetic cardiomyopathy and metabolic remodeling of the heart. Life Sciences, 92(11), 609-615. https://doi.org/10.1016/j.lfs.2012.10.011

Diabetic cardiomyopathy and metabolic remodeling of the heart. / Battiprolu, Pavan K.; Lopez-Crisosto, Camila; Wang, Zhao; Nemchenko, Andriy; Lavandero, Sergio; Hill, Joseph A.

In: Life Sciences, Vol. 92, No. 11, 2013, p. 609-615.

Research output: Contribution to journalArticle

Battiprolu, PK, Lopez-Crisosto, C, Wang, Z, Nemchenko, A, Lavandero, S & Hill, JA 2013, 'Diabetic cardiomyopathy and metabolic remodeling of the heart', Life Sciences, vol. 92, no. 11, pp. 609-615. https://doi.org/10.1016/j.lfs.2012.10.011
Battiprolu, Pavan K. ; Lopez-Crisosto, Camila ; Wang, Zhao ; Nemchenko, Andriy ; Lavandero, Sergio ; Hill, Joseph A. / Diabetic cardiomyopathy and metabolic remodeling of the heart. In: Life Sciences. 2013 ; Vol. 92, No. 11. pp. 609-615.
@article{716efa611c544c3fbbb82321b051394a,
title = "Diabetic cardiomyopathy and metabolic remodeling of the heart",
abstract = "The incidence and prevalence of diabetes mellitus are both increasing rapidly in societies around the globe. The majority of patients with diabetes succumb ultimately to heart disease, much of which stems from atherosclerotic disease and hypertension. However, the diabetic milieu is itself intrinsically noxious to the heart, and cardiomyopathy can develop independent of elevated blood pressure or coronary artery disease. This process, termed diabetic cardiomyopathy, is characterized by significant changes in the physiology, structure, and mechanical function of the heart. Presently, therapy for patients with diabetes focuses largely on glucose control, and attention to the heart commences with the onset of symptoms. When the latter develops, standard therapy for heart failure is applied. However, recent studies highlight that specific elements of the pathogenesis of diabetic heart disease are unique, raising the prospect of diabetes-specific therapeutic intervention. Here, we review recently unveiled insights into the pathogenesis of diabetic cardiomyopathy and associated metabolic remodeling with an eye toward identifying novel targets with therapeutic potential.",
keywords = "Diabetic cardiomyopathy, FoxO, Heart, Insulin resistance, Metabolism, mTOR",
author = "Battiprolu, {Pavan K.} and Camila Lopez-Crisosto and Zhao Wang and Andriy Nemchenko and Sergio Lavandero and Hill, {Joseph A}",
year = "2013",
doi = "10.1016/j.lfs.2012.10.011",
language = "English (US)",
volume = "92",
pages = "609--615",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Diabetic cardiomyopathy and metabolic remodeling of the heart

AU - Battiprolu, Pavan K.

AU - Lopez-Crisosto, Camila

AU - Wang, Zhao

AU - Nemchenko, Andriy

AU - Lavandero, Sergio

AU - Hill, Joseph A

PY - 2013

Y1 - 2013

N2 - The incidence and prevalence of diabetes mellitus are both increasing rapidly in societies around the globe. The majority of patients with diabetes succumb ultimately to heart disease, much of which stems from atherosclerotic disease and hypertension. However, the diabetic milieu is itself intrinsically noxious to the heart, and cardiomyopathy can develop independent of elevated blood pressure or coronary artery disease. This process, termed diabetic cardiomyopathy, is characterized by significant changes in the physiology, structure, and mechanical function of the heart. Presently, therapy for patients with diabetes focuses largely on glucose control, and attention to the heart commences with the onset of symptoms. When the latter develops, standard therapy for heart failure is applied. However, recent studies highlight that specific elements of the pathogenesis of diabetic heart disease are unique, raising the prospect of diabetes-specific therapeutic intervention. Here, we review recently unveiled insights into the pathogenesis of diabetic cardiomyopathy and associated metabolic remodeling with an eye toward identifying novel targets with therapeutic potential.

AB - The incidence and prevalence of diabetes mellitus are both increasing rapidly in societies around the globe. The majority of patients with diabetes succumb ultimately to heart disease, much of which stems from atherosclerotic disease and hypertension. However, the diabetic milieu is itself intrinsically noxious to the heart, and cardiomyopathy can develop independent of elevated blood pressure or coronary artery disease. This process, termed diabetic cardiomyopathy, is characterized by significant changes in the physiology, structure, and mechanical function of the heart. Presently, therapy for patients with diabetes focuses largely on glucose control, and attention to the heart commences with the onset of symptoms. When the latter develops, standard therapy for heart failure is applied. However, recent studies highlight that specific elements of the pathogenesis of diabetic heart disease are unique, raising the prospect of diabetes-specific therapeutic intervention. Here, we review recently unveiled insights into the pathogenesis of diabetic cardiomyopathy and associated metabolic remodeling with an eye toward identifying novel targets with therapeutic potential.

KW - Diabetic cardiomyopathy

KW - FoxO

KW - Heart

KW - Insulin resistance

KW - Metabolism

KW - mTOR

UR - http://www.scopus.com/inward/record.url?scp=84875232063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875232063&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2012.10.011

DO - 10.1016/j.lfs.2012.10.011

M3 - Article

C2 - 23123443

AN - SCOPUS:84875232063

VL - 92

SP - 609

EP - 615

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 11

ER -